Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Hatakeyama

Showing results (41-50 of 415) with videos related to

Pageof 42
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|June 13, 2022
Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomyRyuma Tanaka, Shingo Hatakeyama, Hikari Miura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 16, 2018
Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donorsYuka Kubota, Shingo Hatakeyama, Ikuyo Narita, et al.
Medical Oncology (Northwood, London, England)|May 14, 2017
Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomyDaisuke Noro, Shingo Hatakeyama, Takahiro Yoneyama, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 15, 2019
[Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer]Chikara Ohyama, Tohru Yoneyama, Yuki Tobisawa, et al.
Cell & Bioscience|February 18, 2014
Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancerTatsuo Kido, Stephanie Schubert, Shingo Hatakeyama, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 15, 2013
Tumor targeting by a carbohydrate ligand-mimicking peptideShingo Hatakeyama, Toshiaki K Shibata, Yuki Tobisawa, et al.
International Journal of Nephrology|May 28, 2013
Gene expression changes in venous segment of overflow arteriovenous fistulaYasuhiro Hashimoto, Akiko Okamoto, Hisao Saitoh, et al.
International Journal of Clinical Oncology|September 27, 2012
Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm studyTakuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, et al.
Oncology Letters|November 1, 2017
The role of LIM and SH3 protein-1 in bladder cancer metastasisMisaki Sato, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
The Journal of Urology|June 17, 2008
Enhancement of human sperm motility by trophinin binding peptideShingo Hatakeyama, Kazuhiro Sugihara, Seung Ho Lee, et al.
Pageof 42

Showing results (41-50 of 415) with videos related to

Sort By:
Pageof 42
International Journal of Urology : Official Journal of the Japanese Urological Association|June 13, 2022
Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomyRyuma Tanaka, Shingo Hatakeyama, Hikari Miura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 16, 2018
Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donorsYuka Kubota, Shingo Hatakeyama, Ikuyo Narita, et al.
Medical Oncology (Northwood, London, England)|May 14, 2017
Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomyDaisuke Noro, Shingo Hatakeyama, Takahiro Yoneyama, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 15, 2019
[Development and Clinical Application of Glycan-Targeted Biomarkers for Prostate Cancer]Chikara Ohyama, Tohru Yoneyama, Yuki Tobisawa, et al.
Cell & Bioscience|February 18, 2014
Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancerTatsuo Kido, Stephanie Schubert, Shingo Hatakeyama, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 15, 2013
Tumor targeting by a carbohydrate ligand-mimicking peptideShingo Hatakeyama, Toshiaki K Shibata, Yuki Tobisawa, et al.
International Journal of Nephrology|May 28, 2013
Gene expression changes in venous segment of overflow arteriovenous fistulaYasuhiro Hashimoto, Akiko Okamoto, Hisao Saitoh, et al.
International Journal of Clinical Oncology|September 27, 2012
Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm studyTakuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, et al.
Oncology Letters|November 1, 2017
The role of LIM and SH3 protein-1 in bladder cancer metastasisMisaki Sato, Mihoko Sutoh Yoneyama, Shingo Hatakeyama, et al.
The Journal of Urology|June 17, 2008
Enhancement of human sperm motility by trophinin binding peptideShingo Hatakeyama, Kazuhiro Sugihara, Seung Ho Lee, et al.
Pageof 42